2018
P032 Edta elucidates unexpected crossmatch results
Rewinski M, Doyle P, DeVivo J, Vicki S, Durkin D, Bow L. P032 Edta elucidates unexpected crossmatch results. Human Immunology 2018, 79: 84. DOI: 10.1016/j.humimm.2018.07.090.Peer-Reviewed Original ResearchPatient seraAntibody profileDeceased donor kidney transplantClass IDonor kidney transplantsKidney TxDSA levelsKidney transplantFlow crossmatchUnacceptable antigensCrossmatch resultsT cellsMFI levelsAb reactivityAntibody detectionAsian malesPossible epitopesCourse of monthsSerumAb profilesAO treatmentSignificant differencesSignificant increaseTreatmentDD cells
2012
45-P WHEN A DSA IS NOT A DSA: POSITIVE VIRTUAL CROSSMATCHES RESULTING IN ACTUAL NEGATIVE CROSSMATCHES
Rewinski M, Ortiz J, Bared K, Alberghini T, Bow L. 45-P WHEN A DSA IS NOT A DSA: POSITIVE VIRTUAL CROSSMATCHES RESULTING IN ACTUAL NEGATIVE CROSSMATCHES. Human Immunology 2012, 73: 78. DOI: 10.1016/j.humimm.2012.07.171.Peer-Reviewed Original ResearchDonor-specific antibodiesPositive virtual crossmatchVirtual crossmatchMFI levelsUnacceptable antigensClass ILuminex single antigenNegative flow crossmatchKidney transplant recipientsSuccessful kidney transplantationDonor cellsKidney waiting listPotential kidney recipientsHLA class IKidney recipientsTransplant recipientsKidney transplantationFlow crossmatchAntibody testingNegative crossmatchPatient seraAntibody assaysLuminex assaysWaiting listCrossmatch39-P INCREASING MFI CUTOFFS FOR UNACCEPTABLE ANTIGENS INCREASES ACCESS TO ACTUAL DECEASED DONOR CROSSMATCHES FOR THE SENSITIZED RECIPIENT
Miller M, Alberghini T, Rewinski M, Bow L. 39-P INCREASING MFI CUTOFFS FOR UNACCEPTABLE ANTIGENS INCREASES ACCESS TO ACTUAL DECEASED DONOR CROSSMATCHES FOR THE SENSITIZED RECIPIENT. Human Immunology 2012, 73: 74. DOI: 10.1016/j.humimm.2012.07.165.Peer-Reviewed Original ResearchUnacceptable antigensB cellsB-cell crossmatchPositive flow crossmatchLow-level antibodyHLA class IResultsFifty-sixSensitized recipientsKidney transplantationPositive crossmatchFlow crossmatchVirtual crossmatchDonor workupDP antibodiesNegative control seraLuminex assaysCrossmatchHigh MFI valuesControl seraFlow cytometryMultiple antibodiesClass IRecipientsAntibodiesMatch runs